search
Moderna
In this March 16, 2020 file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren, File)
July 27, 2020, 4:27 pm
US virus vaccine put to final test in thousands of volunteers
Shot developed by NIH and Moderna to be tried on 30,000 people in coming months, with Israel among countries rooting for its success
By AP and TOI staff
A syringe injects an illustrated representation of COVID-19, the disease caused by the novel coronavirus, in Paris, on May 18, 2020. (JOEL SAGET/AFP)
July 19, 2020, 5:55 pm
Report: Israel could end up with coronavirus vaccine — but not enough syringes
Deal for inoculations with US biotech firm Moderna said to not include means to inject vaccine; official warns mass purchase of syringes is vital
By TOI staff
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle, March 16, 2020. (AP/Ted S. Warren, File)
July 15, 2020, 4:40 am
Moderna COVID-19 vaccine to enter final stage trials on July 27
Vaccine shown to provide immune boost in 45 volunteers; ‘No matter how you slice this, this is good news,’ says Dr. Anthony Fauci, US government’s top infectious disease expert
By LAURAN NEERGAARD
A person is injected as part of the first human trials in the UK to test a potential coronavirus vaccine, taken by Oxford University in England, on April 23, 2020. (Screenshot/Oxford University Pool via AP)
June 16, 2020, 2:43 pm
UK begins trial of latest vaccine candidate for coronavirus
British government says 300 healthy people will be immunized with 2 doses of experimental shot developed at Imperial College London, which has been backed by official funding
By Agencies and TOI staff
An entrance to a Moderna, Inc., building, May 18, 2020, in Cambridge, Massachusetts. (AP Photo/Bill Sikes)
June 16, 2020, 11:03 am
Israel said to ink deal with Moderna for potential purchase of COVID-19 vaccine
No details published, but Health Ministry source says no action now would mean waiting a year or more once vaccine is available
By TOI staff and Agencies
In this March 16, 2020, file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in a study volunteers who were given either a low or medium dose. (AP Photo/Ted S. Warren, File)
June 15, 2020, 1:41 am
Israel said near to deal with Moderna to supply experimental coronavirus vaccine
Report comes as countries scramble to ensure they will be among first to receive vaccines, if and when they become available; US biotech company to begin Phase 3 trials next month
By TOI staff and Agencies
An entrance to a Moderna, Inc., building, May 18, 2020, in Cambridge, Massachusetts. (AP Photo/Bill Sikes)
May 28, 2020, 3:21 am
Amid virus vaccine hopes, Moderna top execs said to have sold millions in stocks
US biotech firm’s shares soared when it claimed progress in trials; analysts say sales, including by Israeli chief medical officer, are legal but undermine faith in company
By TOI staff and Agencies
In this March 16, 2020, file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in a study volunteers who were given either a low or medium dose. (AP Photo/Ted S. Warren, File)
May 18, 2020, 9:04 pm
Moderna’s Israeli top medical officer: We’ve shown today that our vaccine works
US biotech firm’s shares soar as it claims tests of first volunteers show its vaccine candidate produces immune response, ‘has potential to prevent COVID-19’; Phase 3 tests in July
By TOI staff and Agencies
Load More
It’s not (only) about you.

Supporting The Times of Israel isn’t a transaction for an online service, like buying Netflix. Our Community is for people like you who care about a common good: ensuring that balanced, independent coverage of Israel and the Jewish world continues to be available to millions across the world, for free.

Read more

Israel becomes stronger from your support - as does the global Jewish community and its friends, who rely on ToI for accurate, timely updates and enriching insights. The Times of Israel is a 24/7 act of Zionism.

Your contribution does entitle you to an ad-free experience on the site and to exclusive content shared only with the ToI Community, like private sessions held weekly with our journalists. But what you really get for as little as $6 per month is the pride of partnership in advancing Israel’s standing, its democracy, and the education of millions.

Our editorial team is, of course, fallible - we make mistakes. But we’re trying - trying to report Israel fairly, and trying, in our analysis and op-eds, to encourage and bolster the best Israel we can. We’re trying to accurately report what’s going on and not sensationalize, and to curate our homepage so that what matters most is prominent.

So please support our work today by becoming a member of The Times of Israel Community - not only for yourself, but also for the health and resilience of Israel and the Jewish world.

* The AD-FREE experience is available for signed-in Community members, on The Times of Israel website on desktop and mobile, and in the iOS and Android apps. Minimal advertising will continue to display on The Times of Israel newsletters.

Join the times of israel community Join our community Already a member? Sign in to stop seeing this